SCHEMBL8375802

SCHEMBL8375802

Oc1ccc(-c2cc(O)no2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
HSD17B1 P14061 1/20 0.51
HSD17B2 P37059 1/20 0.51
NPC1 O15118 6/20 0.50
RAB9A P51151 6/20 0.50
POLB P06746 2/20 0.50
TP53 P04637 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
MLLT1 Q03111 1/20 0.46
KMT2A Q03164 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL788874 0.83 ALDH1A1 (0.44) ALDH1A1HSD17B1HSD17B2NPC1RAB9A
SCHEMBL8377265 0.83 NPC1 (0.50) ALDH1A1NPC1RAB9ATP53HDAC3
SCHEMBL38657732 0.83 PTPN1 (0.61) ALDH1A1NPC1RAB9APOLBTP53
SCHEMBL2959768 0.83 NPC1 (0.56) ALDH1A1NPC1RAB9APOLBTP53
SCHEMBL8380106 0.83 RAB9A (0.57) ALDH1A1HSD17B1HSD17B2NPC1RAB9A
SCHEMBL6938529 0.83 NOTUM (0.61) ALDH1A1NPC1RAB9APOLBTP53
SCHEMBL5157687 0.83 RAB9A (0.61) ALDH1A1NPC1RAB9AKMT2ATDP1
SCHEMBL38658113 0.82 ALDH1A1 (0.43) ALDH1A1HSD17B1HSD17B2NPC1RAB9A
SCHEMBL1180676 0.81 HSD17B1 (0.74) ALDH1A1HSD17B1HSD17B2NPC1RAB9A
SCHEMBL16373702 0.79 ALDH1A1 (0.58) ALDH1A1HSD17B1HSD17B2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
CN-1216986-A Isoxazole derivatives SANKYO CO (JP) 1999-05-19 CN disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed